No Cover Image

Journal article 90 views 14 downloads

Chemically Programmed Vaccines: Iron Catalysis in Nanoparticles Enhances Combination Immunotherapy and Immunotherapy-Promoted Tumor Ferroptosis / Ane Ruiz-de-Angulo; Marc Bilbao Asensio; James Cronin; Stephen Evans; Martin Clift; Jordi Llop; Irene V.J. Feiner; Rhiannon Beadman; Kepa Zamacola Bascarán; Juan Mareque-Rivas

iScience, Volume: 23, Issue: 9, Start page: 101499

Swansea University Authors: Marc, Bilbao Asensio, James, Cronin, Stephen, Evans, Martin, Clift, Rhiannon, Beadman, Juan, Mareque-Rivas

  • 55075.pdf

    PDF | Version of Record

    © 2020 The Authors. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0)

    Download (7.72MB)

Abstract

Immunotherapy has yielded impressive results, but only for a minority of patients with cancer. Therefore, new approaches that potentiate immunotherapy are a pressing medical need. Ferroptosis is a newly described type of programmed cell death driven by iron-dependent phospholipid peroxidation via Fe...

Full description

Published in: iScience
ISSN: 2589-0042
Published: Elsevier BV 2020
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa55075
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: Immunotherapy has yielded impressive results, but only for a minority of patients with cancer. Therefore, new approaches that potentiate immunotherapy are a pressing medical need. Ferroptosis is a newly described type of programmed cell death driven by iron-dependent phospholipid peroxidation via Fenton chemistry. Here, we developed iron oxide-loaded nanovaccines (IONVs), which, chemically programmed to integrate iron catalysis, drug delivery, and tracking exploiting the characteristics of the tumor microenvironment (TME), improves immunotherapy and activation of ferroptosis. The IONVs trigger danger signals and use molecular disassembly and reversible covalent bonds for targeted antigen delivery and improved immunostimulatory capacity and catalytic iron for targeting tumor cell ferroptosis. IONV- and antibody-mediated TME modulation interfaced with imaging was important toward achieving complete eradication of aggressive and established tumors, eliciting long-lived protective antitumor immunity with no toxicities. This work establishes the feasibility of using nanoparticle iron catalytic activity as a versatile and effective feature for enhancing immunotherapy.
Keywords: Immunology, Biomaterials, Nanomaterials, Cancer Therapy
College: College of Science
Issue: 9
Start Page: 101499